Investor Presentation (August)
170830_Investor Presentation Update
News & Announcements from PharmAust in 2017
Shareholders Update
170822_Shareholders Update
Epichem Reports Record $3m Revenues and Expands Laboratory to Accelerate Growth
170717_Epichem Reports Record $3m Revenues and Expands Laboratory to Accelerate Growth
Appendix 4E & Annual Report
170901_Appendix 4E & Annual Report
Appendix 4C – Quarterly Report & Company Update for the period ended 30 June 2017
170801_Appendix 4C – Quarterly Report & Company Update for the period ended 30 June 2017
PharmAust engages Canadian-based specialists to reformulate monepantel
170627_PharmAust engages Canadian-based specialists to reformulate monepantel
PharmAust secures broad European patent for non-cancer applications
170608_PharmAust secures broad European patent for non-cancer applications
PharmAust secures core patent in Japan
170606_PharmAust secures core patent in Japan
PharmAust Shareholders Update and Roadmap
170530_PharmAust Shareholders Update and Roadmap
Phase II dog lymphoma trial preliminary results demonstrate Monepantel clinical benefit
170519_Phase II dog lymphoma trial preliminary results demonstrate Monepantel clinical benefit